title: Variable tissue expression of transferrin receptors: relevance to acute respiratory distress syndrome.
abstract: Acute respiratory distress syndrome (ARDS) is associated with altered plasma and lung iron chemistry. Iron can promote microbial virulence and catalyse pro-oxidant reactions, thereby contributing to the oxidative stress that characterises the syndrome. Therefore, the expression of ferritin and transferrin receptors (TfR) were sought in the lungs and hearts of rodents treated with lipopolysaccharide (LPS), and measurements of TfR and ferritin protein expression were taken from lung biopsy specimens from patients with ARDS and appropriate controls. TfR messenger ribonucleic acid (mRNA) was significantly upregulated in the lungs and significantly downregulated in the hearts of rats 4 h after LPS. Ferritin mRNA levels (light and heavy chains) remained unaltered. Protein TfR levels were significantly upregulated in lungs and downregulated in hearts 4 h post-LPS. Ferritin protein levels were significantly downregulated in lungs compared to baseline values but were unaltered in hearts. Nonhaem iron levels were increased in lungs and decreased in hearts, and iron-regulatory-protein activity increased in hearts but not lungs. TfR protein levels were significantly increased in lung biopsies from patients with ARDS compared to controls. Transferrin receptors are upregulated in rodent lungs during inflammation but are downregulated in the heart. Transferrin receptor protein levels were significantly increased in the lungs in clinical acute respiratory distress syndrome. These findings have implications for the pathogenesis of acute respiratory distress syndrome, especially in relation to the role of iron as a mediator of oxidative stress.
authors.affiliation: Dept of Critical Care, Royal Brompton Hospital, Imperial College Faculty of Medicine, London, UK.
authors.forename: R L
authors.initials: RL
authors.lastname: Upton
authors.forename: Y
authors.initials: Y
authors.lastname: Chen
authors.forename: S
authors.initials: S
authors.lastname: Mumby
authors.forename: J M C
authors.initials: JM
authors.lastname: Gutteridge
authors.forename: P B
authors.initials: PB
authors.lastname: Anning
authors.forename: A G
authors.initials: AG
authors.lastname: Nicholson
authors.forename: T W
authors.initials: TW
authors.lastname: Evans
authors.forename: G J
authors.initials: GJ
authors.lastname: Quinlan
mesh_terms: D000328:Adult; D000368:Aged; D000818:Animals; D002648:Child; D004195:Disease Models, Animal; D025461:Feedback, Physiological / Q000502:physiology; D005260:Female; D005293:Ferritins / Q000378:metabolism*; D006801:Humans; D008070:Lipopolysaccharides / Q000009:adverse effects; D008168:Lung / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D011990:Receptors, Transferrin / Q000378:metabolism*; D012128:Respiratory Distress Syndrome / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology
chemical_list: D008070:Lipopolysaccharides; D011990:Receptors, Transferrin; D005293:Ferritins